Vanda Pharma VNDA reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Vanda Pharma missed estimated earnings by 54.55%, reporting an EPS of $0.05 versus an estimate of $0.11.
Revenue was down $3.51 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 2.04% drop in the share price the next day.
Here’s a look at Vanda Pharma’s past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Vanda Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.